Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases

被引:19
|
作者
Huo, Lanqing [1 ]
Wang, Dan [1 ]
Wang, Wenze [2 ]
Cao, Dongyan [1 ]
Yang, Jiaxin [1 ]
Wu, Ming [1 ]
Yang, Junjun [1 ]
Xiang, Yang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
smooth muscle tumor; uncertain malignant potential; surgical procedure; recurrence; reproductive outcomes; LEIOMYOSARCOMAS; LEIOMYOMAS; EXPRESSION; VARIANTS; STUMP; P16; P53;
D O I
10.3389/fonc.2020.00647
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The term "uterine smooth muscle tumor of uncertain malignant potential" (STUMP) indicates a rare tumor that cannot be classified as a benign leiomyoma or malignant leiomyosarcoma. In this study, we assessed the clinical characteristics, fertility, and oncologic outcomes of patients diagnosed as STUMP in 14 years. In addition, we analyzed the risk factors for recurrence in patients with STUMP. Methods: Medical records of STUMP patients at Peking Union Medical College Hospital (PUMCH) between January 2005 and June 2019 were reviewed and analyzed. Disease-free survival, age of diagnosis, tumor size, surgical procedure, pathology and immunohistochemistry, clinical characteristics, recurrence rate, and reproductive outcomes in the follow-up period were assessed. Univariate and multivariate analyses were performed to determine the prognostic factors. Results: The median age was 42 years old (range: 21-63). Total hysterectomy with or without bilateral salpingo-oophorectomy was performed in 29/67 cases (43.3%), and myomectomy was performed in 38/67 cases (56.7%). Ten patients experienced recurrences, and all but two recurrences occurred within 5 years after the initial surgery. Only two of these recurrences were leiomyosarcoma. There were no deaths in themedian follow-up period of 48.4 (range 2.6-170.2) months. There were no remarkable differences in location of tumor between the myomectomy and hysterectomy groups, but the patients in the myomectomy group were younger than those in the hysterectomy group. In univariate and multivariate analysis, mitosis on pathology was the only independent risk factor for recurrence. Expression of Ki-67, p53, and p16 was significantly higher in patients with recurrence. Seven of the 35 patients who attempted to conceive had successful pregnancies. Conclusions: The prognosis of STUMP was favorable and tumors with more than 10 mitoses per 10 high power field should be monitored closely. The surgical procedure was not an independent risk factor of recurrence, and myomectomy may be an acceptable option for patients wishing to preserve fertility.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] How Much Can We Overcome Uncertainty: A Clinicopathologic Study of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential from a Single Institute
    Maruthi, Vijaya Kadam
    Buza, Natalia
    Dasaraju, Sandhyarani
    Zhong, Minghao
    Hui, Pei
    Sun, Tong
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1172 - S1174
  • [42] Uterine Smooth Muscle of Uncertain Malignant Potential: A Clincopathologic Analysis of 16 Cases from Multiple Centers
    Ip, P. P. C.
    Cheung, A. N. Y.
    Clement, P. B.
    MODERN PATHOLOGY, 2009, 22 : 218A - 218A
  • [43] Clinicopathologic and Molecular Analysis of 25 Cases of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP)
    Umphress, Brandon
    Zhang, Qing
    Wei, Jian-Jun
    MODERN PATHOLOGY, 2017, 30 : 313A - 313A
  • [44] Uterine Smooth Muscle of Uncertain Malignant Potential: A Clincopathologic Analysis of 16 Cases from Multiple Centers
    Ip, P. P. C.
    Cheung, A. N. Y.
    Clement, P. B.
    LABORATORY INVESTIGATION, 2009, 89 : 218A - 218A
  • [45] Clinicopathologic and Molecular Analysis of 25 Cases of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP)
    Uinphress, Brandon
    Zhang, Qing
    Wei, Jian-Jun
    LABORATORY INVESTIGATION, 2017, 97 : 313A - 313A
  • [46] Correction: Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
    Fulvio Borella
    Stefano Cosma
    Domenico Ferraioli
    Isabelle Ray-Coquard
    Nicolas Chopin
    Pierre Meeus
    Vincent Cockenpot
    Giorgio Valabrega
    Giulia Scotto
    Margherita Turinetto
    Nicoletta Biglia
    Luca Fuso
    Luca Mariani
    Dorella Franchi
    Ailyn Mariela Vidal Urbinati
    Ida Pino
    Gianluca Bertschy
    Mario Preti
    Chiara Benedetto
    Isabella Castellano
    Paola Cassoni
    Luca Bertero
    Annals of Surgical Oncology, 2022, 29 : 8319 - 8319
  • [47] Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS)
    Mayerhofer, K
    Lozanov, P
    Bodner, K
    Bodner-Adler, B
    Kimberger, O
    Czerwenka, K
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (11) : 1085 - 1088
  • [48] High 18F-FDG Uptake For Uterine Smooth Muscle Tumor of Uncertain Malignant Potential
    Zhang, Ruiguo
    Tian, Xun
    Qin, Lan
    Lu, Dongyan
    Shen, Jie
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (04) : 349 - 351
  • [49] Ultrasound Appearance of Intravascular Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Case Report
    Montik, Nina
    Grelloni, Camilla
    Filosa, Alessandra
    Goteri, Gaia
    Di Giuseppe, Jacopo
    Natalini, Leonardo
    Ciavattini, Andrea
    DIAGNOSTICS, 2024, 14 (13)
  • [50] Prolapsed Uterine Smooth Muscle Tumor of uncertain Malignant Potential: A Case Report and Review of Radiological Findings
    Jeon, Junhyeon
    Park, Jinyoung
    Lee, Eunjoo
    Han, Jiyeon
    Kim, Dasom
    Park, Jungwon
    Kwag, Minha
    Yun, Suyoung
    Jung, Soo Jin
    CURRENT MEDICAL IMAGING, 2024, 20